Document is current
Any future updates will be listed below
-
Authors
Amar, Anas Ould Si
Hyldstrup, Lars
Nielsen, Jette
Palm, Henrik
Jensen, Jens-Erik Beck
- License Information
-
More Information
Article History
Received: 18 November 2018
Accepted: 28 May 2019
First Online: 19 June 2019
Compliance with ethical standards
:
: Anas Ould Si Amar, Lars Hyldstrup, and Jette Nielsen declare that they have no conflict of interest. Henrik Palm is an advisor for UCB and Amgen, salary to departmental research account, sum below 5.000 euros, and a board member at the Copenhagen Medical Society.Jens-Erik Beck Jensen has received consulting fees from Eli Lilly, Amgen, Gilliad, and MSD and is an advisory board member at Eli Lilly, Amgen, and UCB.
